Aster DM Healthcare has declared an interim dividend of ₹3 per equity share for the financial year 2025-26. The announcement was made during the Board of Directors meeting held on March 26, 2026. The record date for determining the entitlement of shareholders to receive the interim dividend has been set for April 3, 2026.
In accordance with the provisions of the Income-tax Act, 2025, any dividend paid or distributed by a company is taxable in the hands of the shareholders. Consequently, Aster DM Healthcare will deduct tax at source when making the interim dividend payment.
For resident shareholders, the tax deduction at source (TDS) will be applied at a rate of 10% for those with a valid Permanent Account Number (PAN). However, if the PAN is invalid or not linked with an Aadhar number, the TDS rate will be 20%. Exemptions from TDS are available for certain categories, such as insurance companies, mutual funds, and alternative investment funds, upon submission of the requisite documents.
Non-resident shareholders will be subject to a withholding tax rate of 20% or as per the applicable Double Tax Avoidance Agreement (DTAA) between India and their country of residence. To avail of the DTAA benefits, non-resident shareholders must provide a Tax Residency Certificate, a self-declaration in Form 41, and other relevant documents.
The detailed communication regarding the TDS provisions and the necessary annexures to be submitted has been circulated to shareholders whose email addresses are registered with the company or depositories. The information is also available on the company’s website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).